Hypothesis

Aging reduces the abundance of IPA‑producing Clostridium sporogenes in the gut, lowering luminal IPA concentrations below the threshold needed to activate intestinal epithelial PXR. This loss of PXR signaling diminishes tight‑junction protein expression and mucus secretion, compromising barrier integrity and allowing increased bacterial translocation. The resulting endotoxemia fuels systemic low‑grade inflammation (inflammaging), which further suppresses C. sporogenes growth, creating a vicious cycle.

Mechanistic Insight

Beyond its canonical role in upregulating occludin, claudin‑1 and ZO‑1, epithelial PXR activation by IPA induces intestinal alkaline phosphatase (IAP) and Nrf2‑dependent antioxidant genes. IAP dephosphorylates LPS, reducing its potency, while Nrf2 limits mitochondrial ROS that otherwise disrupt junctional complexes. In aged epithelium, blunted PXR activity therefore fails to engage these protective pathways, amplifying both barrier leakiness and oxidative stress.

Testable Predictions

1. Microbial rescue – Aged germ‑free mice colonized with a defined C. sporogenes strain will exhibit luminal IPA concentrations of 30‑50 µM, restore epithelial PXR target gene expression (IAP, Nrf2 targets) and increase transepithelial resistance by ≥60 % compared with age‑matched controls receiving vehicle.
2. Epithelial PXR dependence – Intestinal epithelium‑specific PXR knockout (Vil‑Cre;Nr1i2^fl/fl) aged mice colonized with C. sporogenes will show no improvement in barrier metrics or IAP/Nrf2 activation despite normal luminal IPA levels, confirming that the epithelial PXR axis is required.
3. Human relevance – Colonic organoids derived from donors >65 years will display lower basal IPA‑induced PXR reporter activity and reduced IAP/Nrf2 induction than organoids from donors <35 years; supplementation with 20‑50 µM IPA will rescue the young‑like response only in organoids retaining intact PXR signaling.

Experimental Approach

• Use aged (20‑month) C57BL/6 mice, generate germ‑free cohorts, and colonize with either C. sporogenes or a non‑IPA‑producing control strain.
• Measure luminal IPA by LC‑MS, quantify epithelial PXR target genes (Cyp3a11, IAP, Nqo1) by qPCR, assess barrier function (FITC‑dextran permeability, TEER in Ussing chambers), and score mucus thickness (histology).
• Parallelly, generate Vil‑Cre;Nr1i2^fl/fl aged mice and repeat colonization.
• For human validation, obtain colonic biopsies from young (<35) and old (>65) donors, generate organoids, treat with IPA, and assay PXR‑responsive luciferase, IAP activity, and ROS levels.

Falsifiability

If aged mice colonized with C. sporogenes fail to elevate epithelial PXR target expression or improve barrier function, or if epithelial PXR knockouts still show rescue, the hypothesis would be refuted. Similarly, lack of age‑dependent differences in organoid IPA responsiveness would contradict the proposed mechanism.